TMCI logo

Treace Medical Concepts (TMCI)

Profile

Full Name

Treace Medical Concepts, Inc.

Ticker Symbol

TMCI

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

April 23, 2021

Indexes

Not included

Website

http://www.treace.com

Employees

477

Key Details

Price

$6.76(+0.37%)

Market cap

$423.30M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$209.36M(+11.89% YoY)

Annual EPS

-$0.90(-11.11% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.76
TMCI price is $6.76

30-Day Relative Volume

0.61
TMCI 30-day relative volume is 0.61

Price Performance

Price Today change

+0.37%
TMCI price is up +0.37% today

Price YTD change

-9.14%
TMCI price is down -9.14% since January 1st

Price 1-year change

-43.1%
TMCI price is down -43.1% year-on-year

Price 3-year change

-66.01%
TMCI price is down -66.01% over the past 3 years

Price Range

Price All-time high

$37.17
TMCI price is currently -81.81% below its historical high of $37.17

Price 3-year low

$3.92
TMCI price is currently +72.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$423.30M
TMCI market capitalization is $423.30 million

Market cap 3-year change

-61.5%
TMCI market capitalization is down -61.5% over the past 3 years

Market cap All-time high

$1.90B
TMCI market capitalization is currently -77.78% below its historical high of $1.90 billion

Market cap sector rank

67.21%
TMCI market capitalization is higher than 67.21% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.11%
TMCI shares outstanding is up +1.11% year-on-year

Shares Outstanding 3-Year Change

+13.28%
TMCI shares outstanding is up +13.28% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.20
TMCI beta is 1.20

200-day SMA

$7.33
TMCI price is currently -7.81% below its 200-day simple moving average

50-day SMA

$8.78
TMCI price is currently -23.02% below its 50-day simple moving average

RSI

29.25
TMCI 14-day relative strength index is 29.25

Volume

0.61
TMCI 30-day relative volume is 0.61

ATR

$0.60
TMCI average true range is $0.60

10-day Historical Volatility

57.48%
TMCI 10-day historical volatility is 57.48%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$209.36M
TMCI annual revenue is $209.36 million

Revenue Analysts estimate

$227.53M
TMCI annual revenue is currently -7.99% lower than the consensus analysts' forecast

Revenue 1-year change

+11.89%
TMCI annual revenue is up +11.89% year-on-year

Revenue Sector rank

64.61%
TMCI annual revenue is higher than 64.61% of companies in Healthcare sector

EPS

EPS

-$0.90
TMCI annual earnings per share is -$0.90

EPS Analysts estimate

-$0.85
TMCI annual earnings per share is currently +6.31% higher than the consensus analysts' forecast

EPS 1-year change

-11.11%
TMCI annual earnings per share is down -11.11% year-on-year

EPS Sector rank

59.04%
TMCI annual earnings per share is higher than 59.04% of companies in Healthcare sector

Profit

Gross profit

$168.26M
TMCI annual gross profit is $168.26 million

Gross margin

80.37%
TMCI annual gross profit margin is 80.37%

Operating profit

-$55.69M
TMCI annual operating income is -$55.69 million

Operating margin

-26.60%
TMCI annual operating profit margin is -26.60%

Net income

-$55.74M
TMCI annual net profit is -$55.74 million

Net margin

-26.63%
TMCI annual net profit margin is -26.63%

Expenses

Total expenses

$265.05M
TMCI annual total expenses is $265.05 million

Operating expenses

$223.95M
TMCI annual total operating expenses is $223.95 million

Cost of goods sold

$41.09M
TMCI annual cost of goods sold is $41.09 million

Selling, general & administrative expenses

$203.36M
TMCI annual SGA is $203.36 million

Depreciation and amortization

$8.42M
TMCI annual depreciation & amortization is $8.42 million

Interest expense

$5.26M
TMCI annual interest expense is $5.26 million

Income tax

-
TMCI annual income tax value is unknown

EBIT & EBITDA

EBIT

-$50.49M
TMCI annual earnings before interest & taxes is -$50.49 million

EBITDA

-$42.07M
TMCI annual EBITDA is -$42.07 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$217.09M
TMCI annual total assets is $217.09 million

Non current assets

$55.69M
TMCI annual long term assets is $55.69 million

Current assets

$161.40M
TMCI annual total current assets is $161.40 million

Cash and cash equivalents

$11.35M
TMCI annual cash & cash equivalents is $11.35 million

Accounts receivable

$40.80M
TMCI annual accounts receivable is $40.80 million

Inventory

$39.26M
TMCI annual inventory is $39.26 million

Liabilities

Total liabilities

$104.20M
TMCI annual total liabilities is $104.20 million

Long term liabilities

$69.28M
TMCI annual total long term liabilities is $69.28 million

Current liabilities

$34.92M
TMCI annual total current liabilities is $34.92 million

Accounts payable

$10.52M
TMCI annual accounts payable is $10.52 million

Debt

Total debt

$69.65M
TMCI annual total debt is $69.65 million

Total debt 1-year change

-0.92%
TMCI annual total debt is down -0.92% year-on-year

Long term debt

$69.24M
TMCI annual long term debt is $69.24 million

Short term debt

$413.00K
TMCI annual short term debt is $413.00 thousand

Equity & Capital

Shareholders equity

$112.89M
TMCI annual stockholders equity is $112.89 million

Book value

$112.89M
TMCI annual book value is $112.89 million

Retained earnings

-$189.99M
TMCI annual retained earnings is -$189.99 million

Working capital

$126.48M
TMCI annual working capital is $126.48 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$37.17M
TMCI annual cash flow from operations is -$37.17 million

Cash from operations 1-year change

-7.5%
TMCI annual cash flow from operations is down -7.5% year-on-year

Cash from investing

$35.38M
TMCI annual cash flow from investing activities is $35.38 million

Cash from investing 1-year change

+143.51%
TMCI annual cash flow from investing activities is up +143.51% year-on-year

Cash from financing

$160.00K
TMCI annual cash flow from financing activities is $160.00 thousand

Cash from financing 1-year change

-99.85%
TMCI annual cash flow from financing activities is down -99.85% year-on-year

CAPEX

CAPEX

$11.59M
TMCI annual capital expenditures is $11.59 million

CAPEX 1-year change

+1.18%
TMCI annual capital expenditures is up +1.18% year-on-year

Free Cash Flow

Free cash flow

-$48.76M
TMCI annual free cash flow is -$48.76 million

Free cash flow 1-year change

-5.92%
TMCI annual free cash flow is down -5.92% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

80.37%
TMCI annual gross profit margin is 80.37%

Operating margin

-26.60%
TMCI annual operating profit margin is -26.60%

Net margin

-26.63%
TMCI annual net profit margin is -26.63%

ROA & ROE

ROA

-23.77%
TMCI annual return on assets is -23.77%

ROE

-44.45%
TMCI annual return on equity is -44.45%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TMCI price to earnings ratio value is unknown

PE ratio Sector rank

-
TMCI price to earnings ratio is unknown

PB Ratio

PB ratio

3.75
TMCI price to book ratio is 3.75

PB ratio Sector rank

77.71%
TMCI price to book ratio is higher than 77.71% of companies in Healthcare sector

PS Ratio

PS ratio

2.02
TMCI price to sales ratio is 2.02

PS ratio Sector rank

43.33%
TMCI price to sales ratio is higher than 43.33% of companies in Healthcare sector

Enterprise value

Enterprise value

$481.61M
TMCI enterprise value is $481.61 million

Enterprise value Sector rank

69.2%
TMCI enterprise value is higher than 69.2% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-11.45
TMCI EV/EBITDA is -11.45

EV/EBITDA Sector rank

9.3%
TMCI EV/EBITDA is higher than 9.3% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.62
TMCI annual current ratio is 4.62

Quick ratio

3.50
TMCI annual quick ratio is 3.50

Leverage

Debt to equity

0.47
TMCI annual debt to equity ratio is 0.47

Interest coverage ratio

-9.61
TMCI annual interest coverage ratio is -9.61

Risk & Stability

Piotroski F-Score

3
TMCI piotroski f-score is 3

Altman Z-Score

2.11
TMCI altman z-score is 2.11

Analyst ratings

Recent major analysts updates

Apr 11, 25 Truist Securities
Hold
Mar 13, 25 Truist Securities
Hold
Mar 3, 25 Truist Securities
Hold
Dec 31, 24 Lake Street
Buy
Dec 18, 24 Truist Securities
Hold
Nov 6, 24 Stifel
Hold
Oct 14, 24 Truist Securities
Hold
Aug 7, 24 UBS
Neutral
Aug 7, 24 Truist Securities
Hold
Jul 16, 24 Truist Securities
Hold

Institutional Ownership

Similar stocks

TYRA logo
Tyra Biosciences (TYRA)
Beta Bionics (BBNX)
CAPR logo
Capricor Therapeutics (CAPR)
SIGA logo
SIGA Technologies (SIGA)
TBPH logo
Theravance Biopharma (TBPH)
AKBA logo
Akebia Therapeutics (AKBA)
PGEN logo
Precigen (PGEN)
RLAY logo
Relay Therapeutics (RLAY)
MGTX logo
MeiraGTx Holdings (MGTX)
  • What is the ticker symbol for Treace Medical Concepts?
  • Does Treace Medical Concepts pay dividends?
  • What sector is Treace Medical Concepts in?
  • What industry is Treace Medical Concepts in?
  • What country is Treace Medical Concepts based in?
  • When did Treace Medical Concepts go public?
  • Is Treace Medical Concepts in the S&P 500?
  • Is Treace Medical Concepts in the NASDAQ 100?
  • Is Treace Medical Concepts in the Dow Jones?
  • When was Treace Medical Concepts's last earnings report?
  • When does Treace Medical Concepts report earnings?
  • Should I buy Treace Medical Concepts stock now?

What is the ticker symbol for Treace Medical Concepts?

The ticker symbol for Treace Medical Concepts is NASDAQ:TMCI

Does Treace Medical Concepts pay dividends?

No, Treace Medical Concepts does not pay dividends

What sector is Treace Medical Concepts in?

Treace Medical Concepts is in the Healthcare sector

What industry is Treace Medical Concepts in?

Treace Medical Concepts is in the Medical Devices industry

What country is Treace Medical Concepts based in?

Treace Medical Concepts is headquartered in United States

When did Treace Medical Concepts go public?

Treace Medical Concepts's initial public offering (IPO) was on April 23, 2021

Is Treace Medical Concepts in the S&P 500?

No, Treace Medical Concepts is not included in the S&P 500 index

Is Treace Medical Concepts in the NASDAQ 100?

No, Treace Medical Concepts is not included in the NASDAQ 100 index

Is Treace Medical Concepts in the Dow Jones?

No, Treace Medical Concepts is not included in the Dow Jones index

When was Treace Medical Concepts's last earnings report?

Treace Medical Concepts's most recent earnings report was on Feb 27, 2025

When does Treace Medical Concepts report earnings?

The next expected earnings date for Treace Medical Concepts is May 7, 2025

Should I buy Treace Medical Concepts stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page